Skip to main content
. 2022 May 2;186(5):814–822. doi: 10.1111/bjd.20954

Table 4.

Treatment of hidradenitis suppurativa (HS), overall and by sex

Total (n = 1156) Female (n = 850) Male (n = 306)
Current treatment
Yes, by 49 (11.3) 36 (11.2) 13 (11.6)
General practitioner 18 (37) 14 (39) 4 (31)
Dermatologist 30 (61) 21 (58) 9 (69)
Other specialist < 10 (< 20) < 10 (< 28) < 10 (< 77)
No, reason 384 (88.7) 285 (88.8) 99 (88.4)
HS in remission 131 (34.1) 90 (31.6) 41 (41)
Currently no boils 193 (50.3) 153 (53.7) 40 (40)
Medication has no effect 32 (8.3) 23 (8.1) < 10 (< 10)
Other 28 (7.3) 20 (7.0) 8 (8)
Missing 723 529 194
Treated in the past by
General practitioner 819 (70.8) 598 (70.4) 221 (72.2)
Dermatologist 397 (34.3) 291 (34.2) 106 (34.6)
Other specialists 408 (35.3) 328 (38.6) 80 (26.1)
None 206 (17.8) 157 (18.5) 49 (16.0)
Other 15 (1.3) 10 (1.2) < 10 (< 3.3)

All data are reported as n (%).